1. TMEM139 prevents NSCLC metastasis by inhibiting lysosomal degradation of E‐cadherin
   Shuai Zhang et al, 2022, Cancer Science CrossRef
2. Identification of potential regulatory mechanisms and therapeutic targets for lung cancer
   Anjali Priya et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
3. The Roles of EXO1 and RPA1 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy
   Jia He et al, 2022, Disease Markers CrossRef
4. Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma
   Xiaoguang Qi et al, 2020, PeerJ CrossRef
5. Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma
   Chang-shuai Zhou et al, 2021, OncoTargets and Therapy CrossRef
6. The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities
   Josephine A. Hinneh et al, 2022, Frontiers in Oncology CrossRef
7. Potential biomarkers for lung adenocarcinoma identified by integrative transcriptomics analysis
   Ceyda KASAVİ, 2021, Biotech Studies CrossRef
8. Automated Framework for Exploring Potential Biomarkers in Lung Cancer
   Mohan Kumar Sunil Kumar et al, 2024, 2024 5th International Conference on Smart Electronics and Communication (ICOSEC) CrossRef
9. Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer
   Özgür Cem Erkin et al, 2022, Bioinformatics and Biology Insights CrossRef